nancy lynn MD snyderman Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for nancy lynn MD snyderman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of nancy lynn MD snyderman. nancy lynn MD snyderman is a Director in Lyra Therapeutics, Inc. ($LYRA) and a Director in Alkermes plc. ($ALKS) and a in Axonics Modulation Technologies, Inc. ($AXNX) and a Director in Axonics Modulation Technologies, Inc. ($AXNX).
Address: CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 Ireland
Companies in which nancy lynn MD snyderman is an Insider
Alkermes plc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of nancy lynn MD snyderman: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 16 2021
$ALKS Market Capitalization: $8.28B
$ALKS Previous Close: $54.77
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Axonics, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of nancy lynn MD snyderman:
Holdings: 12,583 shares
Latest Transaction: Aug 26 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Lyra Therapeutics, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of nancy lynn MD snyderman: Director
Holdings: 1,025 shares
Latest Transaction: Dec 17 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of nancy lynn MD snyderman
Sentiment: All, ALKS, AXNX, LYRA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16 2021 | ALKS | Alkermes plc. | snyderman nancy lynn MD | Director | Option Exercise | A | 0.00 | 7,585 | 0 | 7,585 | |
| Jun 16 2021 | ALKS | Alkermes plc. | snyderman nancy lynn MD | Director | Option Exercise | A | 24.72 | 15,677 | 387,535 | 15,677 | |
| Dec 17 2020 | LYRA | Lyra Therapeutics, ... | snyderman nancy lynn MD | Director | Buy | P | 9.72 | 1,025 | 9,963 | 1,025 | 0 to 1 K |
| Dec 04 2020 | ALKS | Alkermes plc. | snyderman nancy lynn MD | Director | Option Exercise | A | 0.00 | 5,578 | 0 | 5,578 | |
| Dec 04 2020 | ALKS | Alkermes plc. | snyderman nancy lynn MD | Director | Option Exercise | A | 18.82 | 11,509 | 216,599 | 11,509 | |
| Aug 26 2020 | AXNX | Axonics Modulation ... | snyderman nancy lynn MD | Grant | A | 0.00 | 3,500 | 0 | 12,583 | 9.1 K to 12.6 K (+38.53 %) | |
| Aug 26 2019 | AXNX | Axonics Modulation ... | snyderman nancy lynn MD | Option Exercise | A | 34.10 | 4,167 | 142,095 | 4,167 |